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Objective: To formulate and evaluate budesonide-pectin beads using novel assembly with a peristaltic pump. 
Methods: The prepared budesonide-pectin dispersion was added to calcium chloride solution with the help of assembly. Provided at least 2 h for 
hardening and dried at 60 °C for 3 h. Assembly was assembled with the use of a peristaltic pump, polymeric solution reservoir, hose, needle, 
magnetic stirrer, gelling bath. One side of hose was dipped in pectin solution container and another side was passed through the peristaltic pump 
and connected to the needle. Peristaltic pump produced pumping of pectin solution through the hose. Needles with variable diameters are available. 
The gelling bath was kept on magnetic stirrer to keep prepared beads in motion, which helped to provide new surface and sufficient reaction time 
and helped to avoid agglomeration. There were 10 different batches with different process parameters prepared. Production yield, the diameter of 
beads, swelling index, and in vitro budesonide dissolution in phosphate buffer pH 7.4 after 5 h was determined.  
Results: There was a significant difference between selection of process parameter among the batches (p = 0.049, q = 6.11). As nozzle diameter was 
increased, percentage yield was decreased (p = 0.0038, q>5.98). However, if hardening time was decreased percentage release was increased (p = 
0.0361, q>5.98). 
Conclusion: The novel assembly for bead generation had developed a uniform, spherical shaped, and smooth surfaced beads. 
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Budesonide is a glucocorticoid [1]. It undergoes significant first-pass 
degradation (80–90%) and is rapidly and extensively bio-
transformed into 6-β-hydroxy budesonide and 16-α-hydroxy 
prednisolone, which has no or negligible (<1/100) targeted pharma-
cological action [2]. Therefore, there is a need for novel drug 
delivery system of it.  
The basic principle for bead generation of is to convert liquid into 
the spherical shape. In resonance method, vibration mechanism was 
used. Assembly consists of liquid reservoir and nozzle. The liquid 
could flow through vibrating nozzle or vibration could be applied to 
the liquid reservoir. Scale-up of the system could be easily possible. 
In the jet cutting method, high pressure is applied to the liquid 
reservoir, resulting in a high-velocity flow of liquid through the 
nozzle in form of a solid-liquid jet. Rotating cutting tool made of 
small wires and driven by the motor is directly placed underneath of 
the jet flowing through the nozzle, which cuts the jet into uniform 
cylindrical segments. These segments convert in spherical beads due 
to surface tension while falling. The spherical beads are falling 
further down to the receiver containing cross-linking agent and a 
hardening agent. Each cutting event causes a cutting loss which is 
slugged a side where it can be gathered and recycled. This technique 
may be useful for various applications in biotechnology, medicine, 
chromatography, pharmaceutical, chemical, and food industries [3]. 
The basic principle of the electrostatic method is to apply an 
electrostatic force to form a charged stream of droplets from a 
nozzle tip. High voltage direct current supply is used to apply to an 
electrostatic potential between droplet formation device 
(nozzle/needle) and collecting solution. Electrostatic force induces a 
charge at the surface of polymer solution flowing through the 
needle, resulting in a decrease in surface tension and formation of 
small-sized droplets [4]. The basic principle of the rotary atomizer is 
to use rotational speed either on disc or multi-nozzle device. In case 
of rotating disc atomizer, the polymer solution is fed onto rotating 
disc whereas, in case of rotating nozzle atomizer, polymer solutions 
flow through the atomizer having multiple nozzles. Optimization of 
rotation speed is vital to formulate uniform sized spherical droplets 
[5]. The assembly of co-axial air stream method has two connections, 
one is attached to the top of the nozzle for polymer solution and 
another is attached to the tip of nozzle to supply air stream. The basic 
principle is to blow polymeric droplets from the nozzle by using co-
axial air stream before they would fall into a gelling reservoir due to 
gravitational force [6]. These presently available methods of beads 
formation have technically complex procedure. Therefore, need of 
simply processed beads formation assembly.  
The objective of the study was to formulate and evaluate budesonide-
pectin beads using novel assembly with a peristaltic pump. 
MATERIALS AND METHODS 
Material 
Budesonide was purchased from Zydus Cadila, Ahmedabad, India. 
Pectin was purchased from Oxford Lab., Mumbai, India. Calcium 
chloride was purchased from Chem. Lab. India. 
Methods 
Preparation of beads 
Accurately weighted pectin was dissolved in the measured volume 
of distilled water with continues agitation to prepare 5% w/v pectin 
solution. To the solution, the accurately weighed budesonide was 
added with continuation agitation to prepare uniform dispersion 
and allowed to stand overnight. The 5% w/v solution of calcium 
chloride was prepared in distilled water. The prepared budesonide-
pectin dispersion was added to calcium chloride solution with the 
help of assembly. Provided at least 2 h for hardening. The hardened 
bead was filtered and washed with fresh water. Drying was done in a 
tray dryer at 60 °C for 3 h. Instrumental setup of the assembly is 
shown in fig. 1. Assembly was assembled with the use of a peristaltic 
pump, polymeric solution reservoir, hose, needle, magnetic stirrer, 
and gelling bath. The one side of hose was dipped in pectin solution 
container, the side was passed through the peristaltic pump and 
connected to the needle. 
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Fig. 1: A novel assembly for bead generation 
 
A peristaltic pump is produced pumping of pectin solution through 
the hose. The desired size of beads was prepared by monitoring and 
maintaining the pumping rate of peristaltic pump depending upon 
the viscosity of the polymeric solution. Needles with variable 
diameters were available. It had chosen on the basis of the viscosity 
of the polymeric solution and desired size of beads. The gelling bath 
was kept on magnetic stirrer to keep prepared beads in motion, 
which helped to provide new surface and sufficient reaction time 
and helped to avoid agglomeration.  
Evaluation of process parameters effects 
There were 10 different batches with different process parameters 
prepared to study the effect of process parameters.  
Evaluation of micrometric properties of beads 
Loading amount of pectin and weight of the dried beads of each 
batch were accurately measured. Production yield (percentage 
yield) was determined as the ratio of the total mass of beads to the 
total mass of raw materials. The diameter of beads was measured by 
Digital vernier caliber (Remi equipment, India). There were 10 g of 
dried beads dipped in a beaker containing 100 ml of 0.1N HCl 
solution. The swollen beads were weighted at a specified time of 30 
min. The swelling index was determined as the ratio of increase in 
weight of beads to initial weight of beads [7]. There was 50 mg 
budesonide loaded beads thoroughly crushed and placed in a 
volumetric flask containing 50 ml of 7.4 pH phosphate buffer for 1 h. 
Budesonide was completely extracted from beads to buffer solution 
by filtration. The sample from the solution was taken to analyze 
spectrophotometrically at 245 nm. The percentage budesonide 
loading was calculated as the ratio of actual budesonide to 
theoretically presence of budesonide [8]. In vitro budesonide 
dissolution in phosphate buffer pH 7.4 after 5 h was determined to 
calculate budesonide release profile of beads [9]. 
Statistical analysis 
All data were represented as mean±SD of three independent 
experiments. One-way ANOVA (analysis of variance, Microsoft 
Excel®
10
 2016, Microsoft Raymond, USA) following the Dunnett 
multiple comparisons test (considering critical value [q]>5.98 as 
significant, InStat Statistica, GraphPad Software, Inc, CA, USA) was 
used to show a significant difference for process parameter and 
evaluation results between different batches [ ]. Results were 
considered significant at 95% of confidence level.  
RESULTS 
There was a significant difference between selection of process 
parameter among the batches (p = 0.049, q = 6.11, table 1). 
Moreover, there was also a significant difference among evaluated 
micrometric properties of different batches such as nozzle diameter 
was increased, percentage yield was decreased (p = 0.0038, q>5.98) 
and if hardening time was decreased percentage release was 
increased (p = 0.0361, q>5.98) (table 2).  
 
Table 1: Process parameter optimization 
Batch  P1 P2 P3 P4 P5 P6 P7 P8 P9 P10 
Addition rate (mL/min.) 1 1 1 1 1 1 1 1 1 Not Fixed 
Stirring speed (rpm) 20 20 20 20 20 20 20 20 20 20 
Drying time (h) 2 2 2 2 2 2 2 2 2 2 
Drying temperature ( °c) 60 60 60 60 60 60 60 60 60 60 
Nozzle diameter (mm) 0.4 0.4 0.4 0.6 0.6 0.6 0.8 0.8 0.8 0.6 
Hardening time (min) 10 20 30 10 20 30 10 20 30 20 
All batches were prepared separately. 
 
Table 2: Results of micrometric properties of beads 
Batch  % Y D (mm) LOD SI % BL % BR 
P1 88.13±1.23 1.076±0.05 83.11±0.49 2.668±0.21 80.88±1.88 97.36±1.23 
P2 86.25±1.25 1.082±0.04 82.97±0.38 2.671±0.23 87.36±1.58 97.55±1.56 
P3 84.23±1.27 1.074±0.06 83.34±0.49 2.663±0.25 83.19±2.36 95.21±1.65 
P4 88.61±1.31 1.098±0.07 83.46±0.28 2.661±0.19 85.23±3.27 99.51±1.69 
P5 85.32±1.33 1.102±0.08 82.87±0.25 2.673±0.18 80.47±2.06 99.31±1.73 
P6 84.27±1.39 1.104±0.09 83.18±0.31 2.666±0.16 82.69±2.49 97.81±1.27 
P7 86.15±1.42 1.114±0.04 82.41±0.19 2.671±0.22 76.18±3.52 98.15±1.17 
P8 88.19±1.43 1.108±0.03 82.36±0.13 2.672±0.29 79.41±3.71 96.76±1.19 
P9 86.28±1.45 1.112±0.07 83.26±1.31 2.642±0.23 82.12±3.52 97.81±1.21 
P10 70.18±1.01 1.248±0.09 80.36±1.68 2.682±0.28 70.18±4.12 96.23±1.12 
* 0.0038 p 0.0103 0.0026 0.0392 0.0451 0.0361 
* >5.98 q >5.98 >5.98 >5.98 >5.98 >5.98 
Data were represented as mean±SD, n = 3, Y: Yield, D: Average diameter, LOD: Loss on drying, SW: Swelling Index, BL: budesonide loading, BR: 
budesonide release, p<0.05 and q>5.98 were considered as significant, *Overall value. 
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The present intention was to set up with novel assembly at 
laboratory scale to formulate beads. Traditionally, one of the multi-
particulate dosage form (beads) is prepared by filling polymer 
solution in the syringe, at laboratory scale. Several difficulties arise 
at the time of preparation and optimization of formulation such as to 
obtain smaller beads with narrow size distribution, to get 
morphological ununiformed, tedious bulk production, and lengthy 
process [11]. The present process of beads formation was provided 
morphologically uniform, desire sized beads with narrow size 
distribution, and facilitate automation for bulk production. 
The present work was stressed on process parameters. Process 
parameters had shown major influence on the physical appearance 
and micrometric properties (particle size, flow, and compressibility) 
of the prepared beads [12]. In respect to the results of process 
parameters, handling capacity of the assembly and primary 
optimization of process parameters were evaluated based on 
morphologic studies (appearance and shape).  
CONCLUSION 
The process experimental study was used novel assembly for bead 
generation and developed a uniform, spherical shaped, and smooth 
surfaced beads. With help of changes in process parameters, there 
could be possible to get beads with desired morphological 
properties. However, there is a need for modification in assembly for 
the scale-up process at the industrial level.  
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